Literature DB >> 25962655

The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model.

David A Margolin1, Tamara Myers1, Xin Zhang1, Danielle M Bertoni1, Brian A Reuter1, Izi Obokhare1, Theodor Borgovan1, Chelsea Grimes1, Heather Green1, Tiffany Driscoll1, Chung-Gi Lee1, Nancy K Davis1, Li Li2.   

Abstract

Colorectal cancer (CRC) is the second-most common cause of cancer-related mortality. The most important prognostic factors are lymph node (LN) involvement and extranodal metastasis. Our objective is to investigate the interactions between CD133(+)CXCR4(+) (CXC receptor 4) colorectal cancer tumor-initiating cells (Co-TICs) and the LN stromal microenvironment in human CRC extranodal metastasis. We established a unique humanized orthotopic xenograft model. Luciferase-tagged CRC cell lines and human cancer cells were injected intrarectally into nonobese diabetic/SCID mice. Mesenteric LN stromal cells, stromal cell line HK, or CXCL12 knockdown HK (HK-KD-A3) cells were coinoculated with CRC cells. Tumor growth and metastasis were monitored by bioluminescent imaging and immunohistochemistry. We found that this model mimics the human CRC metastatic pattern with CRC cell lines or patient specimens. Adding LN stromal cells promotes CRC tumor growth and extranodal metastasis (P < 0.001). Knocking down CXCL12 impaired HK cell support of CRC tumor formation and extranodal metastasis. When HK cells were added, sorted CD133(+)CXCR4(+) Co-TICs showed increased tumor formation and extranodal metastasis capacities compared to unseparated and non-Co-TIC populations. In conclusion, both Co-TIC and LN stromal factors play crucial roles in CRC metastasis through the CXCL12/CXCR4 axis. Blocking Co-TIC/LN-stromal interactions may lead to effective therapy to prevent extranodal metastasis. © FASEB.

Entities:  

Keywords:  HK cell; cancer stem cell; intrarectal injection; xenograft

Mesh:

Substances:

Year:  2015        PMID: 25962655     DOI: 10.1096/fj.14-268938

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Modeling of Patient-Derived Xenografts in Colorectal Cancer.

Authors:  Anastasia Katsiampoura; Kanwal Raghav; Zhi-Qin Jiang; David G Menter; Andreas Varkaris; Maria P Morelli; Shanequa Manuel; Ji Wu; Alexey V Sorokin; Bahar Salimian Rizi; Christopher Bristow; Feng Tian; Susan Airhart; Mingshan Cheng; Bradley M Broom; Jeffrey Morris; Michael J Overman; Garth Powis; Scott Kopetz
Journal:  Mol Cancer Ther       Date:  2017-05-03       Impact factor: 6.261

2.  CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin.

Authors:  Yaowu He; Claire M Davies; Brittney S Harrington; Linh Hellmers; Yonghua Sheng; Amy Broomfield; Thomas McGann; Kate Bastick; Laurie Zhong; Andy Wu; Grace Maresh; Shannon McChesney; Kuan Yau Wong; Mark N Adams; Ryan C Sullivan; James S Palmer; Lez J Burke; Adam D Ewing; Xin Zhang; David Margolin; Li Li; Rohan Lourie; Admire Matsika; Bhuvana Srinivasan; Michael A McGuckin; John W Lumley; John D Hooper
Journal:  Oncogene       Date:  2019-08-30       Impact factor: 9.867

3.  The Molecular Basis of Metastatic Colorectal Cancer.

Authors:  Sarah F Andres; Kathy N Williams; Anil K Rustgi
Journal:  Curr Colorectal Cancer Rep       Date:  2018-03-01

4.  Fibroblastic reticular cells of the lymphoid tissues modulate T cell activation threshold during homeostasis via hyperactive cyclooxygenase-2/prostaglandin E2 axis.

Authors:  Miao Yu; Gang Guo; Xin Zhang; Li Li; Wei Yang; Roni Bollag; Yan Cui
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

5.  Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.

Authors:  Armel Herve Nwabo Kamdje; Paul Takam Kamga; Richard Tagne Simo; Lorella Vecchio; Paul Faustin Seke Etet; Jean Marc Muller; Giulio Bassi; Erique Lukong; Raghuveera Kumar Goel; Jeremie Mbo Amvene; Mauro Krampera
Journal:  Cancer Biol Med       Date:  2017-05       Impact factor: 4.248

6.  Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas.

Authors:  Azam Mardani; Elmira Gheytanchi; Seyed Hamzeh Mousavie; Zahra Madjd Jabari; Tina Shooshtarizadeh
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

Review 7.  Mouse models of colorectal cancer: Past, present and future perspectives.

Authors:  Florian Bürtin; Christina S Mullins; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

Review 8.  Could gastrointestinal tumor-initiating cells originate from cell-cell fusion in vivo?

Authors:  Yang Zhou; Jun-Ting Cheng; Zi-Xian Feng; Ying-Ying Wang; Ying Zhang; Wen-Qi Cai; Zi-Wen Han; Xian-Wang Wang; Ying Xiang; Hui-Yu Yang; Bing-Rong Liu; Xiao-Chun Peng; Shu-Zhong Cui; Hong-Wu Xin
Journal:  World J Gastrointest Oncol       Date:  2021-02-15

9.  A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis.

Authors:  Jessie Gills; Ravan Moret; Xin Zhang; John Nelson; Grace Maresh; Linh Hellmers; Daniel Canter; M'Liss Hudson; Shams Halat; Marc Matrana; Michael P Marino; Jakob Reiser; Maureen Shuh; Eric Laborde; Maria Latsis; Sunil Talwar; Stephen Bardot; Li Li
Journal:  Oncotarget       Date:  2018-08-24

10.  A Pilot Study Investigating the Expression Levels of Pluripotency-Associated Genes in Rectal Swab Samples for Colorectal Polyp and Cancer Diagnosis and Prognosis.

Authors:  Ryan Wai-Yan Sin; Dominic Chi-Chung Foo; Deepak Narayanan Iyer; May Sau-Yee Fan; Xue Li; Oswens Siu-Hung Lo; Wai-Lun Law; Lui Ng
Journal:  Stem Cells Int       Date:  2021-07-22       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.